Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesis

Human Pathology

Volumn 40, Issue 9, 2009, Pages 1252-1261

  Lazzi, Stefano ^a   Bellan, Cristiana ^a   Onnis, Anna ^a   De Falco, Giulia ^a   Sayed, Shahin ^a   Kostopoulos, Ioannis ^b   Onorati, Monica ^a   D'Amuri, Alessandro ^a   Santopietro, Rosa ^a   Vindigni, Carla ^a   Fabbri, Alberto ^a   Righi, Simona ^c   Pileri, Stefano ^c   Tosi, Piero ^a   Leoncini, Lorenzo ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Aberrant expression of B and T cell markers; Extranodal NK T cell lymphoma; Immunohistochemistry; Immunophenotype; Molecular analysis; Pax5

Indexed keywords

B LYMPHOCYTE ANTIGEN; IMMUNOGLOBULIN LIGHT CHAIN; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR PAX5;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; DENDRITIC CELL; DNA METHYLATION; FEMALE; FOLLICULAR LYMPHOMA; GENE INACTIVATION; GENE REARRANGEMENT; GRANULOCYTE; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPHOCYTE DIFFERENTIATION; LYMPHOPOIESIS; MACROPHAGE; MALE;

AGED; ANTIGENS; B-CELL-SPECIFIC ACTIVATOR PROTEIN; B-LYMPHOCYTES; BIOLOGICAL MARKERS; DNA METHYLATION; FATAL OUTCOME; FEMALE; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOMA; MALE; MIDDLE AGED;

EID: 68349150326     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.01.007     Document Type: Article

References (43)

1. Forestier E., Nordenson I., Lindstrom A., Roos G., and Lindh J. Simultaneous immunoglobulin/T-cell receptor gene rearrangements and multiclonality in childhood acute lymphoblastic leukemia. Acta Pediatr 83 (1994) 319-326
2. Gloeckner-Hofmann K., Ottesen K., Schmidt S., Nizze H., Feller A.C., and Merz H. T-cell/natural killer lymphoblastic lymphoma with an unusual coexpression of B-cell antigens. Ann Hematol 79 (2000) 635-639
3. Liang R., Chan V.V., Chan T.K., Chiu E., and Todd D. Rearrangement of immunoglobulin and T cell receptor genes in acute and chronic Leukemias. Acta Haematol 85 (1991) 71-75
4. Schroff R.W., and Foon K.A. Heterogeneity in a lymphoid tumor: coexpression of T and B surface markers. Blood 60 (1982) 373-380
5. Hanawa H., Abo J., Inokuchi K., et al. Dual rearrangement of immunoglobulin and T-cell receptor genes in a case of splenic lymphoma with villous lymphocytes. Leuk Lymphoma 18 (1995) 357-360
6. Inaba T., Shimazaki C., Sumikuma T., and Nakagawa M. T-cell associated antigen-positive B-cell lymphoma. Leuk Lymphoma 42 (2001) 1161-1171
7. Potti A., Malik A.A., Ganti A.K., Koch M., and Leitch J. Immunoglobulin and T-cell receptor gene-gene rearrangement in pleural cavity-based T-cell rich B-cell lymphoma in an immunocompetent patient. Leuk Lymphoma 43 (2002) 195-198
8. Palumbo A.P., Corradini P., Battaglio S., et al. Dual rearrangement of immunoglobulin and T-cell receptor genes in a case of T-cell hairy-cell leukemia. Eur J Haematol 46 (1991) 71-76
9. Schmidt C.J., Domenico L., Ward P., Barcos M.P., and Stewart C.C. Aberrant antigen expression detected by multiparameter three color flow cytometry in intermediate and high grade B-cell lymphomas. Leuk Lymphoma 34 (1999) 539-544
10. Blakolmer K., Vesely M., Kummer J.A., Jurecka W., Mannhalter C., and Chott A. Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T-(NK/T) cell lymphomas. Mod Pathol 13 (2000) 766-772
11. Sun T., Akalin A., Rodacker M., and Braun T. CD20 positive T cell lymphoma: is it a real entity?. J Clin Pathol 57 (2004) 442-444
12. Went P., Agostinelli C., Gallamini A., et al. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol 24 (2006) 2472-2479
13. Quintanilla-Martinez L., Preffer F., Rubin D., Ferry J.A., and Harris N.L. CD20 + T-cell lymphoma. Neoplastic transformation of a normal T-cell subset. Am J Clin Pathol 102 (1994) 483-489
14. Yao X., Teruya-Feldstein J., Raffeld M., Sorbara L., and Jaffe E.S. Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall. Mod Pathol 14 (2001) 105-110
15. Magro C.M., Seilstad K.H., Porcu P., and Morrison C.D. Primary CD20+ CD10+ CD8+ T-cell lymphoma of the skin with dual IgH an TCRβ gene rearrangement. Am J Clin Pathol 126 (2006) 14-22
16. World Health Organization classification of tumours. Pathology and genetics: tumours of haematopoietic and lymphoid tissues. In: Vardiman JW, editor. Lyon, France: IARC Press, International Agency for Research on Cancer; 2001.
17. Quong M.W., Romanow W.J., and Murre C. E protein function in lymphocyte development. Ann Rev Immunol 20 (2002) 301-322
18. Enver T. B-cell commitment: Pax5 is the deciding factor. Curr Biol 9 (1999) 933-935
19. Fuxa M., and Busslinger M. Reporter gene insertions reveal a strictly B lymphoid-specific expression pattern of Pax-5 in support of its B cell identity function. J Immunol 178 (2007) 3031-3037
20. Cattoretti G., Pileri S., Parravicini C., et al. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 171 (1993) 79-80
21. Falini B., Abdulaziz Z., Gerdes J., et al. Description of a sequential staining procedure for double immunoenzymatic staining of pairs of antigens using monoclonal antibodies. J Immunol Methods 93 (1986) 265-273
22. Bellan C., De Falco G., Lazzi S., et al. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation. J Pathol 203 (2004) 946-952
23. van Dongen J.J., Lagerak A.W., Bruggmann M., et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspected lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17 (2003) 2257-2317
24. van Krieken J.H.J.M., Langerak A.W., Macintyre E.A., et al. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 21 (2007) 201-206
25. Bellan C., Lazzi S., Zazzi M., et al. Immunoglobulin gene rearrangement analysis in composite Hodgkin's disease and large B cell lymphoma: evidence for receptor revision of immunoglobulin heavy chain variable region genes in Hodgkin Reed-Sternberg cells?. Diagn Mol Pathol 11 (2002) 2-8
26. Palmisano W.A., Crume K.P., Grimes M.J., et al. Aberrant promoter methylation of the transcription factor genes PAX5 alpha and beta in human cancer. Cancer Res 63 (2003) 4620-4625
27. Nutt S.L., Urbanek P., Rolink A., and Busslinger M. Essential functions of Pax5(BSAP) in pro-B cell development: difference between fetal and adult B lymphopoeisis and reduced V-to-DJ recombination at the IgH locus. Genes Dev 11 (1997) 476-491
28. Uike N., Takeichi N., Kimura N., Takahira H., and Kozuru R. Dual rearrangement of immunoglobulin an T-cell receptor genes in a blast crisis of CML. Eur J Haematol 42 (1989) 460-465
29. Wakimoto N., Mukai Y., Kuwada N., et al. Dual rearrangement of immunoglobulin and T-cell receptor genes in a case of Philadelphia chromosome-positive acute leukemia. Jpn J Clin Oncol 28 (1998) 396-400
30. Busslinger M., Nutt S.L., and Rolink A.G. Lineage commitment in lymphopoiesis. Curr Opin Immunol 12 (2000) 151-158
31. Busslinger M. Transcriptional control of early B cell development. Annu Rev Immunol 22 (2004) 55-79
32. Cotta C.V., Zhang Z., Kim H.G., and Klug C.A. Pax5 determines B-versus T-cell fate and does not block early myeloid-lineage development. Blood 101 (2003) 4342-4346
33. Hoflinger S., Kesavan K., Fuxa M., et al. Analysis of Notch1 function by in vitro T cell differentiation of Pax5 mutant lymphoid progenitors. J Immunol 173 (2004) 3935-3944
34. Rolink A.G., Schaniel C., Bruno L., and Melchers F. In vitro and in vivo plasticity of Pax5-deficient pre-B I cells. Immunol Lett 82 (2002) 35-40
35. Mikkola I., Heavey B., Horcher M., and Busslinger M. Reversion of B cell commitment upon loss of Pax5 expression. Science 297 (2002) 110-113
36. Horcher M., Souabni A., and Busslinger M. Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis. Immunity 14 (2001) 779-790
37. Cabaleda C., Jochun W., and Busslinger M. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 449 (2007) 473-477
38. Esteller M. Cancer epigenetics: DNA methylation and chromatin alterations in human cancer. Adv Exp Med Biol 532 (2003) 39-49
39. Bergman Y., Fisher A., and Cedar H. Epigenetic mechanisms that regulate antigen receptor gene expression. Curr Opin Immunol 15 (2003) 176-181
40. Kay P.H., Spagnolo D.V., Taylor J., and Ziman M. DNA methylation and development genes in lymphomagenesis-more questions than answers?. Leuk Lymphoma 24 (1997) 211-220
41. Pasqualucci L., Neumeister P., Goossens T., et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412 (2001) 341-346
42. Yu D., Allman D., Goldschmidt M.H., Atchinson M.L., Monroe J.G., and Thomas-Tikhonenko A. Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway. Blood 101 (2003) 1950-1955
43. Clark S.J., and Melki J. DNA methylation and gene silencing in cancer: which is the guilty party?. Oncogene 21 (2002) 5380-5387